Drug: Bevacizumab Injury: Hypokalaemia Quarter: 2016Q3
Total Records: 43 Number of Pages: 3
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
73689983 | Bevacizumab | Hypokalaemia | ROCHE | 75.00 YR | F | 76 KG | 20160913 | US |
78696174 | Bevacizumab | Hypokalaemia | ROCHE | 0.00 | F | 55 KG | 20160805 | US |
79980283 | Bevacizumab | Hypokalaemia | ROCHE | 53.00 YR | F | 91 KG | 20160930 | US |
82290393 | Bevacizumab | Hypokalaemia | ROCHE | 59.00 YR | F | 105 KG | 20160929 | US |
83404846 | Bevacizumab | Hypokalaemia | ROCHE | 63.00 YR | F | 116 KG | 20160927 | US |
85629496 | Bevacizumab | Hypokalaemia | ROCHE | 67.00 YR | M | 50 KG | 20160929 | US |
86174952 | Bevacizumab | Hypokalaemia | ROCHE | 8.00 YR | M | 22 KG | 20160909 | US |
86818712 | Bevacizumab | Hypokalaemia | ROCHE | 74.84 YR | M | 85 KG | 20160914 | US |
89228356 | Bevacizumab | Hypokalaemia | ROCHE | 0.00 | 0 | 20160914 | US | |
94583572 | Bevacizumab | Hypokalaemia | ROCHE | 66.00 YR | F | 54 KG | 20160929 | US |
97780392 | Bevacizumab | Hypokalaemia | ROCHE | 62.00 YR | F | 65 KG | 20160929 | US |
104404043 | Bevacizumab | Hypokalaemia | ROCHE | 67.60 YR | M | 95 KG | 20160711 | DE |
108120013 | Bevacizumab | Hypokalaemia | ROCHE | 77.00 YR | F | 71 KG | 20160930 | US |
125297161 | Bevacizumab | Hypokalaemia | CIPLA | 0.00 | 0 | 20160706 | US | |
125404372 | Bevacizumab | Hypokalaemia | ROCHE | 66.00 YR | M | 55 KG | 20160808 | US |
125483631 | BEVACIZUMAB | Hypokalaemia | MERCK | 0.00 | 0 | 20160712 | US | |
125484302 | Bevacizumab | Hypokalaemia | ROCHE | 83.00 YR | F | 70 KG | 20160916 | US |
126155961 | BEVACIZUMAB | Hypokalaemia | BRISTOL MYERS SQUIBB | 51.00 YR | M | 0 | 20160802 | US |
126491563 | BEVACIZUMAB | Hypokalaemia | PFIZER | 52.00 YR | M | 0 | 20160929 | AU |
126523501 | BEVACIZUMAB | Hypokalaemia | TEVA | 52.00 YR | M | 0 | 20160815 | AU |
Total Records: 43 Number of Pages: 3